생물적 병해충 방제 시장 : 병해충 유형별, 작물 유형별, 방제 방법별, 적용 방식별, 최종 사용자별 예측(2026-2032년)

The Biological Pest Control Market was valued at USD 1.55 billion in 2025 and is projected to grow to USD 1.63 billion in 2026, with a CAGR of 6.94%, reaching USD 2.48 billion by 2032.

Opening the narrative on biological pest control by framing scientific advances operational realities regulatory pressures and stakeholder expectations driving adoption

Biological pest control is transitioning from a niche scientific endeavour to a commercial and operational priority across agriculture, horticulture, and managed landscapes. This introduction synthesizes the current landscape, clarifies the scientific rationale for biological approaches, and frames the strategic imperatives that are shaping stakeholder behavior. Growing interest in reduced chemical dependence, coupled with advancements in microbial formulations, beneficial arthropods, and application technologies, has created a richer toolkit for integrated pest management programs.

The science underpinning biological controls reflects advances in strain selection, formulation stability, and delivery systems that improve efficacy and handling across diverse environments. Simultaneously, supply chain actors are adapting to differing cold-chain needs and regulatory dossiers, which in turn influences commercialization timelines. From an operational perspective, adoption decisions increasingly hinge on demonstrable performance in field conditions, compatibility with crop protection programs, and clear guidance for end users. Pest managers, extension services, and institutional buyers are seeking reliable evidence on efficacy, persistence, and non-target effects.

This introduction positions the remainder of the analysis by identifying the critical intersections between innovation, regulation, and adoption. It sets expectations for how scientific validation, application modes, and user education must co-evolve to enable broader uptake. By orienting readers to these drivers, the section prepares decision-makers to interpret subsequent insights with focus on implementation feasibility, operational risk, and value realization.

Identifying transformative shifts reshaping biological pest management from innovation pipelines to regulatory evolution and farmer adoption dynamics

The landscape for biological pest management is undergoing a series of transformative shifts that reconfigure competitive dynamics and deployment models. Technological advances are broadening the palette of available solutions, including refined biopesticide formulations, targeted pheromone-based interventions, and mass-rearing improvements for parasitoids and predators. These scientific improvements are enabling longer shelf life, enhanced specificity, and better integration with precision application technologies, thereby reducing barriers to field adoption.

Parallel to technological change, regulatory ecosystems are evolving to better accommodate living organisms and novel biochemical agents. Regulatory authorities are increasingly developing pathways that balance environmental safety with accelerated review for products with clear ecological benefits. This regulatory evolution is reshaping product development strategies, nudging firms to invest earlier in compliance data packages and to engage proactively with registries and risk assessors.

In addition, stakeholder expectations are shifting as supply chain actors emphasize sustainability credentials and traceability. Retailers, food processors, and institutional buyers are beginning to factor biological control solutions into procurement criteria, creating demand-side pull for validated, label-ready products. Finally, operational models are changing as service providers, extension networks, and digital advisory platforms scale their ability to support adoption at farm level. Taken together, these shifts create a new operational template where innovation, regulation, and buyer expectations funnel toward pragmatic, evidence-based deployment.

Assessing the cumulative effects of United States tariff measures in 2025 on supply chains sourcing strategies and international trade dynamics in biological controls

United States tariff actions in 2025 introduced discrete pressures across international supply chains that source biological inputs, raw materials for formulations, and specialized equipment. These trade measures have prompted firms to revisit sourcing strategies and to evaluate the resilience of critical supply nodes. For organizations that depended on cross-border suppliers for microbial strains, fermentation equipment, or packaging components, tariff-induced cost pressures have accelerated considerations around nearshoring, supplier diversification, and contract renegotiation.

From a practical perspective, companies have responded by reassessing supplier qualification frameworks and augmenting their procurement playbooks to prioritize redundancy and localized inventory buffers. Contract manufacturing and private-label arrangements have reemerged as risk-mitigation options where manufacturers can flex capacity without long-term capital exposure. In parallel, some players have accelerated investments in regional production capabilities to reduce exposure to customs volatility and to improve responsiveness to seasonal demand.

The tariff environment has also elevated the importance of logistics optimization, including improved forecasting, incremental freight strategies, and customs intelligence integration. Organizations that combine operational adjustments with product reformulation to lower reliance on tariff-exposed inputs can preserve commercial momentum. Looking forward, trade policy shifts will continue to shape strategic choices around manufacturing footprints, partner selection, and inventory strategies, reinforcing the need for scenario-based planning and agile commercial operations.

Deriving actionable segmentation insights across pest type crop type control method application mode and end user to inform product and channel strategies

Segmentation insights clarify how product development, commercialization, and channel strategies must be tailored to distinct pest, crop, control method, application mode, and end-user contexts. When considering pest type, formulations tailored for fungal challenges must address taxonomic diversity across Ascomycetes, Basidiomycetes, and Oomycetes, while insect-targeted solutions need specificity across Coleoptera, Hemiptera, and Lepidoptera. Nematode management calls for approaches calibrated to cyst, lesion, and root-knot variants, whereas weed control requires agents or approaches differentiated for broadleaf, grasses, and sedges. This biological granularity dictates R&D prioritization, efficacy testing regimes, and label claims.

Crop type segmentation further refines product positioning and deployment: field crops demand scale-ready solutions compatible with cereals, oilseeds, and pulses; fruits and vegetables require high-precision compatibility with crop-specific cycles such as apples, cucumbers, grapes, and tomatoes; ornamentals and turf present unique stewardship and aesthetic considerations whether managing annuals and perennials or servicing golf courses and residential landscapes. Each crop context imposes constraints on residue expectations, application timing, and compatibility with integrated pest management calendars.

Control method segmentation underscores the need for diversified portfolios. Biochemical controls such as pheromones and repellents offer behavioral management pathways, parasitoids delivered via flies and wasps introduce biological suppression strategies, pathogens including bacteria, fungi, nematodes, and viruses provide agent-specific modes of action, and predators such as lacewings, ladybugs, and predatory mites support conservation biocontrol and augmentative releases. Application mode differentiation across aerial platforms including fixed wing and rotary, greenhouse systems using drip and fogging, and ground techniques from broadcast to soil drench and sprayers with varying volume profiles requires compatibility testing and operational guidance. Finally, end-user segmentation across crop producers, government agencies, landscape managers, and research institutions affects procurement cycles, technical service needs, and the adoption horizon. Integrating these segmentation vectors enables firms to target product claims, demonstration trials, and go-to-market models with precision.

Interpreting regional nuances across the Americas Europe Middle East and Africa and Asia Pacific to guide deployment partnerships and localized product positioning

Regional dynamics vary materially and must inform strategic choices around distribution, regulatory engagement, and product adaptation. In the Americas, diverse production systems from large-scale field cropping to intensive specialty fruit and vegetable operations create a heterogeneous demand base that values scalability, cost-effectiveness, and demonstrable field performance. North American regulatory frameworks and extension systems support structured introduction of biologicals, while Latin American markets often prioritize affordability and supply chain resilience.

The Europe Middle East and Africa region presents a complex mosaic where stringent regulatory scrutiny in parts of Europe coexists with rapid adoption opportunities in horticultural and high-value crop segments. Regulatory emphasis on environmental protection and integrated pest management has created demand for biologically based solutions that can demonstrably reduce chemical load. In parts of the Middle East and Africa, climatic considerations and crop mixes necessitate product robustness under heat stress and saline conditions, creating opportunities for formulations optimized for local agroecologies.

Asia Pacific exhibits both high-volume agricultural demand and vibrant innovation ecosystems. Diverse cropping patterns and high-intensity vegetable production drive interest in precise, high-efficacy biologicals, while dense smallholder systems emphasize ease of use, clear instructions, and low-cost application modalities. Regional manufacturing capacity, a mature biotech supply chain in certain countries, and active research institutions create pathways for collaboration and rapid scale-up, provided that regulatory and registration strategies are aligned with local requirements. Tailoring go-to-market approaches to these regional nuances will be essential for effective uptake and sustained impact.

Profiling strategic company trends and competitive movements among leading innovators scale up manufacturers and niche biological control providers

Company-level dynamics reveal a spectrum of strategic approaches from research-led innovators to contract manufacturers and vertically integrated suppliers. Leading innovators prioritize deep biological expertise, investments in strain selection, and field validation to create differentiated efficacy profiles. These organizations often pursue strategic collaborations with academic institutions and contract research organizations to accelerate applied research and to access diversified trial environments.

Contract manufacturers and scale-up specialists play a pivotal role by enabling smaller innovators to commercialize without large capital investments. This operational model supports rapid market entry but requires rigorous quality assurance systems to ensure consistency across batches and to meet regulatory expectations. At the same time, incumbent agricultural chemical firms increasingly explore partnerships and acquisitions to broaden their integrated pest management portfolios, integrating biologicals alongside conventional options to offer hybrid solutions that meet diverse customer needs.

Across the competitive landscape, firms that combine product performance with strong technical support, clear labeling, and scalable supply chains gain traction. Investment in demonstrable field data, user-friendly application guidance, and post-sale support strengthens adoption. Strategic players also differentiate through service models such as on-farm demonstrations, subscription-based supply packages, and training programs for distributors and applicators. These company-level choices will determine how quickly biological solutions move from demonstration projects to routine practice.

Translating market intelligence into actionable recommendations for industry leaders to accelerate adoption optimize operations and align with regulatory change

Industry leaders should prioritize a set of pragmatic actions to accelerate adoption, manage operational risk, and capture commercial opportunity. First, integrate cross-functional teams that combine R&D, regulatory affairs, and commercial leaders to streamline product development pathways and to anticipate compliance data needs. Coordinated planning reduces time lost to rework and enables earlier engagement with regulators and key customers. Second, invest in regional manufacturing partnerships or dual-sourcing strategies to mitigate trade and logistics exposure while preserving cost discipline.

Third, build robust field validation programs that emphasize comparative performance in realistic operational conditions and provide clear guidance on integration with crop protection calendars. Evidence-driven demonstration programs reduce perceived risk among end users and facilitate retailer and processor acceptance. Fourth, develop tailored go-to-market approaches that reflect crop type, application mode, and end-user constraints; a one-size-fits-all commercialization plan will underperform in the face of biological and operational diversity.

Fifth, strengthen extension and technical support capabilities through training, digital advisory tools, and accessible agronomic materials. Effective support models address applicator competence and build trust in biological solutions. Finally, pursue strategic collaborations with research institutions, extension services, and logistics partners to accelerate innovation diffusion and to ensure operational readiness. Together these actions form a coherent playbook for leaders seeking to scale biological pest control responsibly and profitably.

Outlining a rigorous research methodology integrating primary interviews laboratory data synthesis field trial observations and supply chain analysis techniques

This research employed a multi-layered methodology designed to integrate laboratory science, field observation, stakeholder interviews, and supply chain analysis. Primary research comprised structured interviews with agronomists, product developers, regulatory specialists, and commercial managers, combined with observational inputs from field trials and demonstration plots. Laboratory data synthesis included cross-referencing strain performance characteristics, formulation stability profiles, and compatibility testing with common application systems.

Field trial observations were selected to represent varied agroecological zones and crop systems to ensure practical relevance across different pest and crop contexts. Supply chain and logistics analyses examined sourcing pathways, manufacturing capacities, and distribution constraints, with attention to tariff sensitivities and cold-chain requirements. Triangulation across these data streams ensured that technical performance, operational feasibility, and commercial considerations were integrated into the final analysis.

Throughout the process, quality controls included independent validation of trial methodologies, peer review of analytical assumptions, and sensitivity checks on strategic implications. Ethical considerations and adherence to applicable biosafety guidelines were maintained in all primary research activities. The resulting methodological approach provides a defensible basis for interpreting product performance, operational challenges, and strategic options for stakeholders.

Concluding strategic reflections on biological pest control progress persistent barriers to adoption and the practical path forward for scalable sustainable protection

The conclusion synthesizes the report's principal lessons and underscores a pragmatic path forward for stakeholders committed to sustainable pest management. Biological pest control solutions have moved into a phase where scientific sophistication, regulatory clarity, and buyer expectations converge to enable wider deployment. Yet, systemic barriers remain, including supply chain fragility, the need for regionally relevant efficacy data, and the imperative for clear application guidance to ensure consistent field performance.

Overcoming these barriers requires coordinated action across the value chain: developers must prioritize robustness and user-friendliness in product design, regulatory bodies should continue to refine proportionate pathways for living agents and novel biochemicals, and buyers should integrate biological solutions into procurement strategies supported by technical service frameworks. When these conditions align, biologicals can deliver meaningful reductions in chemical reliance while supporting crop protection goals.

Ultimately, the path forward is iterative. Continuous field validation, investment in localized manufacturing and distribution, and sustained engagement with growers and advisors will be necessary to realize the potential of biological pest control at scale. The conclusion emphasizes realistic, evidence-based steps that stakeholders can take to convert innovation into predictable operational value.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Pest Control Market, by Pest Type

• 8.1. Fungal
  • 8.1.1. Ascomycetes
  • 8.1.2. Basidiomycetes
  • 8.1.3. Oomycetes
• 8.2. Insect
  • 8.2.1. Coleoptera
  • 8.2.2. Hemiptera
  • 8.2.3. Lepidoptera
• 8.3. Nematode
  • 8.3.1. Cyst
  • 8.3.2. Lesion
  • 8.3.3. Root-Knot
• 8.4. Weed
  • 8.4.1. Broadleaf
  • 8.4.2. Grasses
  • 8.4.3. Sedges

9. Biological Pest Control Market, by Crop Type

• 9.1. Field Crops
  • 9.1.1. Cereals
  • 9.1.2. Oilseeds
  • 9.1.3. Pulses
• 9.2. Fruits Vegetables
  • 9.2.1. Apples
  • 9.2.2. Cucumbers
  • 9.2.3. Grapes
  • 9.2.4. Tomatoes
• 9.3. Ornamentals

10. Biological Pest Control Market, by Control Method

• 10.1. Biochemical Controls
  • 10.1.1. Pheromones
  • 10.1.2. Repellents
• 10.2. Parasitoids
  • 10.2.1. Flies
  • 10.2.2. Wasps
• 10.3. Pathogens
  • 10.3.1. Bacteria
  • 10.3.2. Fungi
  • 10.3.3. Nematodes
  • 10.3.4. Viruses
• 10.4. Predators
  • 10.4.1. Lacewings
  • 10.4.2. Ladybugs
  • 10.4.3. Predatory Mites

11. Biological Pest Control Market, by Application Mode

• 11.1. Aerial
  • 11.1.1. Fixed Wing
  • 11.1.2. Rotary
• 11.2. Greenhouse
  • 11.2.1. Drip
  • 11.2.2. Fogging
• 11.3. Ground
  • 11.3.1. Broadcast
  • 11.3.2. Soil Drench
  • 11.3.3. Sprayers

12. Biological Pest Control Market, by End User

• 12.1. Crop Producers
• 12.2. Government Agencies
• 12.3. Landscape Managers
• 12.4. Research Institutions

13. Biological Pest Control Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Biological Pest Control Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Biological Pest Control Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. United States Biological Pest Control Market

17. China Biological Pest Control Market

18. Competitive Landscape

• 18.1. Market Concentration Analysis, 2025
  • 18.1.1. Concentration Ratio (CR)
  • 18.1.2. Herfindahl Hirschman Index (HHI)
• 18.2. Recent Developments & Impact Analysis, 2025
• 18.3. Product Portfolio Analysis, 2025
• 18.4. Benchmarking Analysis, 2025
• 18.5. AgBiome, Inc.
• 18.6. Andermatt Group AG
• 18.7. BASF SE
• 18.8. Bayer AG
• 18.9. Biobest Group NV
• 18.10. BioWorks, Inc.
• 18.11. Certis Biologicals
• 18.12. Chr. Hansen Holding A/S
• 18.13. Corteva, Inc.
• 18.14. FMC Corporation
• 18.15. Jiangsu Tuoqiu Agricultural Science and Technology Co., Ltd.
• 18.16. Koppert Biological Systems B.V.
• 18.17. Lallemand Plant Care
• 18.18. Marrone Bio Innovations, Inc.
• 18.19. Novozymes A/S
• 18.20. Som Phytopharma India Limited
• 18.21. Sumitomo Chemical Co., Ltd.
• 18.22. Syngenta AG
• 18.23. UPL Limited
• 18.24. Valent BioSciences LLC
• 18.25. Zhejiang Sega Science and Technology Co., Ltd.